Euroapi Fair Value Cut to €1.48 as Analysts Reset Views

Analysts have lowered the fair value estimate for Euroapi (ENXTPA:EAPI) from €2.00 to approximately €1.48, and cut the key price target from €2.90 to €1.70, according to Simply Wall St. These revisions reflect a reset in expectations as analysts reassess the balance between potential upside and execution risk.

Rating Change

• Previous Fair Value: €2.00
• New Fair Value: €1.48
• Previous Price Target: €2.90
• New Price Target: €1.70

Analyst Rationale

Analysts believe previous estimates were overly optimistic, and execution risks (e.g., production delays, regulatory issues) justify lower valuations. Increased competition in the active pharmaceutical ingredient (API) sector may also pressure margins.

Context

This downgrade follows a period of volatility for Euroapi shares, which have traded near the new target. Other analysts have not yet commented, but Simply Wall St notes the updated model brings price targets closer to the current trading range.

What to Make of It

While the stock may appear undervalued after the cut, execution risks remain. Investors should monitor quarterly reports and management updates to gauge whether the new targets are achievable.